ERYTECH Pharma S.A. (ERYP) reports Q3 results

ERYTECH Pharma S.A. (NASDAQ: ERYP) reported Q3 results. Revenue for the quarter came in at $25.77 million versus the consensus estimate of $2.83 million.

For earnings history and earnings-related data on ERYTECH Pharma S.A. (ERYP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c